Atlas Trials

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

Clinical trial NCT02457221 · COMPLETED

Trial details

NCT number
NCT02457221
Sponsor
Astellas Pharma China, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lupus Nephritis
Start date
2015-03-10
Primary completion
2018-09-10
Enrollment
314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.